Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Mimedx (MDXG) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Mimedx (MDXG) over the last 16 years, with Q3 2025 value amounting to 0.75.

  • Mimedx's Equity Ratio rose 93.07% to 0.75 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.75, marking a year-over-year increase of 93.07%. This contributed to the annual value of 0.73 for FY2024, which is 2255.8% up from last year.
  • Latest data reveals that Mimedx reported Equity Ratio of 0.75 as of Q3 2025, which was up 93.07% from 0.74 recorded in Q2 2025.
  • Mimedx's 5-year Equity Ratio high stood at 0.75 for Q1 2025, and its period low was 0.11 during Q3 2022.
  • For the 5-year period, Mimedx's Equity Ratio averaged around 0.27, with its median value being 0.0 (2021).
  • In the last 5 years, Mimedx's Equity Ratio crashed by 2414783.62% in 2022 and then surged by 1044782.0% in 2024.
  • Over the past 5 years, Mimedx's Equity Ratio (Quarter) stood at 0.0 in 2021, then plummeted by 24147.84% to 0.1 in 2022, then surged by 668.98% to 0.6 in 2023, then increased by 22.56% to 0.73 in 2024, then rose by 2.37% to 0.75 in 2025.
  • Its Equity Ratio was 0.75 in Q3 2025, compared to 0.74 in Q2 2025 and 0.75 in Q1 2025.